BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18192839)

  • 41. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Ali MA; Jin J; Keefe DL
    J Hypertens; 2008 Mar; 26(3):589-99. PubMed ID: 18300872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.
    Connell JM; Fraser R; MacKenzie SM; Friel EC; Ingram MC; Holloway CD; Davies E
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):243-7. PubMed ID: 15134824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDR1 genotype-dependent regulation of the aldosterone system in humans.
    Zolk O; Jacobi J; Pahl A; Fromm MF; Schmieder RE
    Pharmacogenet Genomics; 2007 Feb; 17(2):137-44. PubMed ID: 17301693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
    Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
    Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of aldosterone levels by -344 C/T CYP11B2 polymorphism and spironolactone use in resistant hypertension.
    Fontana V; de Faria AP; Barbaro NR; Sabbatini AR; Modolo R; Lacchini R; Moreno H
    J Am Soc Hypertens; 2014 Mar; 8(3):146-51. PubMed ID: 24388430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Associations between aldosterone synthase gene polymorphisms and left ventricular structure and function in Chinese normal Han People].
    Rao L; Zhang Q; Liang W; Huang M; Zhang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jan; 34(1):70-1, 74. PubMed ID: 15600184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of Angiotensin-converting enzyme gene polymorphism with effect of antihypertensive therapy by Angiotensin-converting enzyme inhibitor.
    Li X; Du Y; Du Y; Huang X
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):25-30. PubMed ID: 12652327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association between aldosterone synthase gene polymorphism and hypertrophic cardiomyopathy].
    Chen AH; Zhang WX; Li ZL; Tang XM; Lu Q; Qian XX; Li LY; Sun JZ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):704-6. PubMed ID: 12376254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.
    Adamzik M; Frey UH; Bitzer K; Jakob H; Baba HA; Schmieder RE; Schneider MP; Heusch G; Peters J; Siffert W
    Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenine/cytosine(1166) polymorphism of the angiotensin II type 1 receptor gene and the antihypertensive response to angiotensin-converting enzyme inhibitors.
    Yu H; Lin S; Jin L; Yu Y; Zhong J; Zhang Y; Liu G
    J Hypertens; 2009 Nov; 27(11):2278-82. PubMed ID: 19680137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake.
    Rajput C; Makhijani K; Norboo T; Afrin F; Sharma M; Pasha ST; Pasha MA
    J Hypertens; 2005 Jan; 23(1):79-86. PubMed ID: 15643128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension.
    Nejatizadeh A; Kumar R; Stobdan T; Goyal AK; Gupta M; Javed S; Pasha MQ
    J Hypertens; 2008 Jun; 26(6):1094-101. PubMed ID: 18475146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.
    Milionis HJ; Kostapanos MS; Vakalis K; Theodorou I; Bouba I; Kalaitzidis R; Georgiou I; Elisaf MS; Siamopoulos KC
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):181-9. PubMed ID: 18205097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects.
    Cadée JA; Chang CY; Chen CW; Huang CN; Chen SL; Wang CK
    Am J Hypertens; 2007 Jan; 20(1):1-5. PubMed ID: 17198904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The -2548G/A LEP polymorphism is associated with blood pressure in Tunisian obese patients.
    Ben Ali S; Kallel A; Ftouhi B; Sediri Y; Feki M; Slimane H; Jemaa R; Kaabachi N
    Blood Press; 2008; 17(5-6):278-83. PubMed ID: 18923972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.